Table 1 Baseline Characteristics
level | Overall | Not vaccinated | Dose 1 | Dose 2 | Dose 3 | p | |
|---|---|---|---|---|---|---|---|
Number | 2, 104 | 119 (5.7%) | 39 (1.9%) | 540 (25.7%) | 1, 406 (66.8%) | ||
Gender (%) | Male | 1,073 (51.0) | 83 (69.7) | 24 (61.5) | 282 (52.2) | 684 (48.6) | < 0.001 |
Female | 1,031 (49.0) | 36 (30.3) | 15 (38.5) | 258 (47.8) | 722 (51.4) | ||
Age (median [IQR]) | 38.00 [31.00, 49.00] | 36.00 [27.50, 47.00] | 34.00 [27.00, 45.00] | 34.50 [28.00, 46.00] | 39.00 [33.00, 49.00] | < 0.001 | |
Age (%) | < 18y | 96 (4.6) | 21 (17.6) | 6 (15.4) | 69 (12.8) | 0 (0.0) | < 0.001 |
18-60y | 1,984 (94.3) | 93 (78.2) | 33 (84.6) | 465 (86.1) | 1,393 (99.1) | ||
> 60y | 24 (1.1) | 5 (4.2) | 0 (0.0) | 6 (1.1) | 13 (0.9) | ||
Chronic Disease History (%) | yes | 1,812 (86.1) | 89 (74.8) | 33 (84.6) | 477 (88.3) | 1,213 (86.3) | 0.002 |
no | 292 (13.9) | 30 (25.2) | 6 (15.4) | 63 (11.7) | 193 (13.7) | ||
Surgical history(%) | yes | 1,787 (84.9) | 96 (80.7) | 30 (76.9) | 462 (85.6) | 1,199 (85.3) | 0.268 |
no | 317 (15.1) | 23 (19.3) | 9 (23.1) | 78 (14.4) | 207 (14.7) | ||
Allergic history(%) | yes | 1,980 (94.1) | 108 (90.8) | 36 (92.3) | 512 (94.8) | 1,324 (94.2) | 0.371 |
no | 124 (5.9) | 11 (9.2) | 3 (7.7) | 28 (5.2) | 82 (5.8) | ||
Last vaccine to being positive (median [IQR]) | 327.00 [281.00, 406.00] | NA | 476.00 [361.50, 498.50] | 465.00 [441.50, 489.00] | 307.00 [268.00, 334.00] | < 0.001 | |
Time to negative conversion (median [IQR]) | 11.00 [9.00, 13.00] | 12.00 [10.00, 15.00] | 12.00 [10.00, 15.00] | 11.00 [9.00, 14.00] | 11.00 [9.00, 13.00] | 0.001 | |
Time to negative conversion (mean [SD]) | 11.43 (4.31) | 12.57 (5.05) | 12.18 (3.46) | 11.67 (4.86) | 11.22 (4.02) | 0.002 |